Effect of Telmisartan Versus Captopril on Insulin Resistance in Hypertensive Type 2 Diabetic Patients

Effect of Telmisartan Versus Captopril on Insulin Resistance in Hypertensive Type 2 Diabetic Patients

Background and objectives: Hypertension is an extremely common co-morbid condition in diabetes. Peripheral insulin resistance (IR) plus compensatory hyperinsulinaemia is a common mechanism underlying both hypertension and diabetes. The aim of this study was to compare the effects of telmisartan a...

Full description

Bibliographic Details
Main Authors:	Adnan Ali Zainal, Fadhel Abbas Al-Hamamy
Format:	Article
Language:	English
Published:	College of Nursing,University of Mosul 2014-12-01
Series:	مجلة الموصل للتمريض
Subjects:	captopril homa-ir telmisartan type 2 diabetes.
Online Access:	https://mjn.mosuljournals.com/article_162935_589c01b3c915330d42bb15218acdb437.pdf

Similar Items

Clinical sub typing of newly detected type 2 diabetics on the basis of pancreatic beta cell function and degree of insulin resistance and their clinical characterization
by: Avijit Saha
Published: (2022-05-01)

Functional Interactomes of Genes Showing Association with Type-2 Diabetes and Its Intermediate Phenotypic Traits Point towards Adipo-Centric Mechanisms in Its Pathophysiology
by: Aditya Saxena, et al.
Published: (2020-04-01)

Serum magnesium status and its correlation with insulin resistance in newly diagnosed patients with type 2 diabetes mellitus
by: Mohammed Ruhul-Kabir, et al.
Published: (2019-04-01)

Effects of Sublingual Captopril in Immediate Treatment of Hypertensive Crisis
by: Hashem Kazerani, et al.
Published: (2007-06-01)

Utilidad del índice HOMA-IR con una sola determinación de insulinemia para diagnosticar resistencia insulínica Usefulness of HOMA-IR index with an only insulinemia determination to diagnose an insulin resistance
by: José Arturo Hernández Yero, et al.
Published: (2011-08-01)

Role of Beta Cell Function and Insulin Resistance in the Development of Gestational Diabetes Mellitus
by: Jonas Ellerbrock, et al.
Published: (2022-06-01)

Red dragon fruit juice in reducing ros levels and insulin resistance In rats with type 2 diabetes mellitus model
by: Mahendri Deayu Putri, et al.
Published: (2021-12-01)

Dyslipidemia in diabetes: a population-based study in Bali
by: Suastika K, et al.
Published: (2019-09-01)

Avaliação do perfil lipídico de pacientes diabéticos e hipertensos tratados com captopril Evaluation of lipid profile in diabetic and hypertensive patients treated with captopryl
by: Fernanda Bernardes Fernandes Santos, et al.
Published: (2009-06-01)

comparison of serum visfatin levels in restricted diet rats,type2 diabetic rats and insulin resistance rats with normal rats
by: mohammadali ghaffari, et al.
Published: (2015-11-01)

comparison of serum visfatin levels in restricted diet rats,type2 diabetic rats and insulin resistance rats with normal rats
by: mohammadali ghaffari, et al.
Published: (2015-11-01)

Eficacia de la microdosis de captopril en el tratamiento de la hipertensión arterial esencial Effectiveness of captopril microdosing in the treatment of essential arterial hypertension
by: Tomás Noel Santana Téllez, et al.
Published: (2012-09-01)

Immune pleiotropic effect of telmisartan in arterial hypertension
by: N. M. Agarkov, et al.
Published: (2022-07-01)

Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk
by: Karunee Kwanbunjan, et al.
Published: (2018-05-01)

Telmisartan and cardioprotection
by: McFarlane S
Published: (2011-11-01)

The Antihypertensive Efficacy of Chlorthalidone and Telmisartan in Indian Hypertensive Patients who were Uncontrolled with Hydrochlorothiazide and Telmisartan Combination-A Prospective and an Open Label Study
by: Suresh V Sagarad, et al.
Published: (2014-04-01)

Efecto de telmisartan sobre marcadores del remodelado óseo en pacientes hipertensos Telmisartan effect's on remodelling bone markers in hypertensive patients
by: J. L. Pérez-Castrillón, et al.
Published: (2012-02-01)

A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients
by: Plavnik Frida Liane, et al.
Published: (2002-01-01)

Does Ramadan fasting affect glicemic control in patients with diabetes mellitus? effects of fasting on betatrophin and insulin resistance
by: Mustafa Timurkaan, et al.
Published: (2022-03-01)

Comparative Study of High Dose Mono-Therapy of Amlodipine or Telmisartan, and Their Low Dose Combination in Mild to Moderate Hypertension
by: Jaswant Goyal, et al.
Published: (2014-06-01)

Effects of Combination Therapy with Captopril and Angiotensin II on the Viability of Random-pattern Skin Flaps in Diabetic Rat Model
by: Binevş Heja Aygören, et al.
Published: (2016-12-01)

A Meta-analysis of antihypertensive effect of telmisartan versus candesartan in patients with essential hypertension
by: Di Zhao, et al.
Published: (2019-01-01)

Telmisartan versus metformin in downregulating myostatin gene expression and enhancing insulin sensitivity in the skeletal muscles of type 2 diabetic rat model
by: Ahmed Abd-Eltawab Tammam, et al.
Published: (2023-07-01)

Telmisartan increases hepatic glucose production via protein kinase C ζ-dependent insulin receptor substrate-1 phosphorylation in HepG2 cells and mouse liver
by: Kae Won Cho, et al.
Published: (2019-01-01)

Serum vitamin D status and its relationship with insulin resistance amongst a cohort of Nigerian patients with type 2 diabetes mellitus
by: Jokotade O Adeleye, et al.
Published: (2023-01-01)

A comparative study on the pleiotropic effects of Olmesartan and Telmisartan in hypertensive patients with type 2 diabetes mellitus: A randomized, prospective, open labelled, hospital based study
by: Vineela Karthik N, et al.
Published: (2023-07-01)

Association of Serum Ferritin Levels with Metabolic Syndrome and Insulin Resistance
by: Meghana. K. Padwal, et al.
Published: (2015-09-01)

Perioperative cardiovascular assessment of hypertensive patients treated with enalapril or captopril
by: Sarah Pías-Solis, et al.
Published: (2022-08-01)

Effects of Captopril and Losartan on Cardiac Stereology in Rats with Renovascular Hypertension
by: Ali Akbar Nekooeian, et al.
Published: (2021-05-01)

Preptin and Myostatin Independently Increase in Pre-Diabetics and Patients of Type 2 Diabetes Mellitus
by: Saeed Nazari Soltan Ahmad, et al.
Published: (2019-05-01)

Effect of Telmisartan on the Regression of the Left Ventricular Hypertrophy in the Patients of Essential Hypertension
by: Kumar Haraprasad Misra, et al.
Published: (2013-07-01)

Association between cognitive impairment patient with solid cancer and insulin resistance
by: Kenji Gonda, et al.
Published: (2019-10-01)

TELMISARTAN IN THE TREATMENT OF ARTERIAL HYPERTENSION. CASE STUDY
by: V. I. Podzolkov, et al.
Published: (2015-12-01)

Pengaruh Puguntano terhadap HOMA-IR Pada Pasien Diabetes Melitus yang Baru Didiagnosis
by: Billy Stinggo Siahaan, et al.
Published: (2017-06-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension
by: Koshlia V.I., et al.
Published: (2016-09-01)

Features of change of intracardiac gemodynamics and functional state of myocardium under the impact of telmisartan in patients with hypertension.
by: V. I. Koshlia, et al.
Published: (2015-09-01)

Urban environment as an independent predictor of insulin resistance in a South Asian population
by: Mohan Thanikachalam, et al.
Published: (2019-02-01)

Ausência de efeito do captopril no metabolismo de uma emulsão lipídica artificial semelhante aos quilomícrons em pacientes hipertensos e hipercolesterolêmicos Lack of effect of captopril on the metabolism of an artificial lipid emulsion similar to chylomicrons in hypertensive hypercholesterolemic patients
by: Renato J. Alves, et al.
Published: (2004-12-01)

Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
by: Maryam Paseban, et al.
Published: (2019-03-01)

Does Omega-3 Fatty Acid Supplementation Have Beneficial Effects on Plasma Homocysteine, Insulin Resistance and Lipid Profile of Type 2 Diabetic Patients? A Randomized Clinical Trial
by: Faezeh Poursoleiman, et al.
Published: (2018-01-01)